-
Keep That Colonoscopy AppointmentExperts weigh in on a recent study appearing to show that colonoscopy had lower-than-expected efficacy for preventing colorectal cancer.
by Pamela Rafalow Grossman
-
What We Know About Ultraprocessed Foods and Cancer RiskResearch has linked highly processed foods like deli meat to a higher risk of colorectal cancer in men.
by Jon Kelvey
-
Exploring a New FrontierAACR patient advocate forum addresses developments in cancer early detection tests.
by Thomas Celona
-
Forward Look
A New Breast Cancer SubtypeClinical trial results are changing care for people with metastatic breast cancer that expresses low levels of HER2 protein.
by Kris Conner
-
Cancer and AlcoholLowering and increasing alcohol consumption is associated with changes in cancer risk.
by Teresa Bergen
-
Thinking Outside the ClinicResearchers highlight need for outreach and educational programs to address survivorship disparities.
by Thomas Celona
-
Forward Look
Can Understanding Long COVID-19 Teach Us About Chemo Brain?Cognitive effects from COVID-19 and cancer treatment look very similar. Collaboration may lead to better treatment for both.
by Erin O'Donnell
-
Chemo or Not?Tumor profiling tests that predict the likelihood of distant recurrence can help some women with early-stage, hormone receptor-positive breast cancer decide on treatments after surgery.
by Kris Conner
-
Forward Look
Black Patients Less Likely to Receive Targeted RadiationStudy finds racial disparities in the use of proton beam therapy, a focused treatment that can reduce side effects.
by Carolyn Bernhardt
-
Forward Look
Targeting Cancer in KidsNew studies probe how to match targeted therapies to children with cancer.
by Stephen Ornes
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff
-
AACR Grant Propels Progress in Immunotherapy ResearchA grant from the American Association for Cancer Research (AACR) helped Marco Ruella, MD, develop a new approach to immunotherapy.
-
Self-screening for Cancer: Home Sweet HomeNew cervical cancer self-screening options and a portable blood test device could lead to changes in at-home cancer screening.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
